You are here: vision-research.eu » News

News

Biden pursues giant boost for science spending

US president’s first budget proposal emphasizes applied research and public health, and aims to tackle climate change and racial injustice.

Essilor to Present New Results for its Stellest Lens for Children With Myopia

Essilor will unveil pivotal 2-year clinical trial results of its Stellest lens for myopia. The 2-year results demonstrate that Essilor Stellest lenses slow down myopia progression by 67% on average, when compared to single vision lenses, when worn at least 12 hours a day, according to Essilor.

‘We must adapt’: EU research chief on Europe’s €100-billion funding programme

Commissioner Mariya Gabriel will oversee the implementation of the Horizon Europe scheme.

New Mechanisms for Reversing Age-Related Disease described

Life Biosciences announces research in Nature describing new mechanisms for reversing Age-Related Disease

Discovery of a new drug for diabetic retinopathy

A potentially effective treatment for diabetic retinopathy, a disease that swells and scars the retina, has been developed by an Université de Montréal scientist and investigator at Maisonneuve-Rosemont Hospital Research Centre (MRH-RC).

Publication of Preclinical Efficacy Results on IOP-Lowering Compounds announced

Nicox SA anounces the publication of Preclinical Efficacy Results on a new class of Non-PGA NO-Donating IOP-Lowering Compounds

COVID-19 linked to potentially dangerous eye abnormalities

Researchers using MRI have found significant abnormalities in the eyes of some people with severe COVID-19, according to a study published in the journal Radiology.

Bausch + Lomb Launches Alaway Preservative Free Antihistamine Eye Drops

Bausch + Lomb announced the US launch of Alaway Preservative Free (ketotifen fumarate ophthalmic solution 0.035%) antihistamine eye drops. Bausch + Lomb says Alaway is the first and only over-the-counter (OTC) preservative-free antihistamine eye itch relief drop approved by the FDA.

Treating vision loss globally would have social and economic benefits

Written by 73 leading experts from 25 countries, The Lancet Global Health Commission Report on Global Eye Health reveals that with the right tools, strategies, and sufficient funding, improving eye health can have immediate and substantial benefits for the economic and social prosperity of individuals and nations.

Topcon announces US Launch of the Harmony Glaucoma Module

Topcon Healthcare announced it has launched its new Glaucoma Module feature for the Harmony Clinical Data Management Solution.

New therapeutic approach may help treat age-related macular degeneration effectively

Runt-related transcription factor 1 (RUNX1) has been linked to retinal neovascularization and the development of abnormal blood vessels, which result in vision loss in diabetic retinopathy. Now, scientists have found that RUNX1 inhibition presents a new therapeutic approach in the treatment of age-related macular degeneration (AMD), which is the leading cause of blindness in the elderly worldwide.

FCI Ophthalmics announces availability of LacriJet for Monocanalicular Nasolacrimal Intubation

FCI Ophthalmics announced the launch of the LacriJet in the United States. It is the first, self-retaining monocanalicular nasolacrimal intubation preloaded on a single use injector, according to FCI Ophthalmics.

VRmagic Eyesi Slit Lamp Fundoscopy Module Launched in the UK

VRmagic’s new Fundoscopy Module can be mounted to the Eyesi Slit Lamp simulator table to enable a lifelike interaction. It is supported by comprehensive software offering a wide selection of cases for retinal examination, which will be continuously extended, according to a company news release.

Doctors reverse jumping vision caused by light deprivation

Gradual exposure to light restored vision to a migraine sufferer who developed miner's nystagmus after an extended period of severe light deprivation, reports a team led by UCL experts.

How Europe's €100 billion science fund will shape 7 years of research

Horizon Europe, the world’s largest multinational research and innovation programme, has issued its first call for grant applications.